Cancer Diagnostics Market Share, Size, Trends and Revenue Models 2021

29/gen/2018 11:51:09 Research Cosmos Contatta l'autore

Questo comunicato è stato pubblicato più di 3 mesi fa. Le informazioni su questa pagina potrebbero non essere attendibili.

In this region, global cancer diagnostics is projected to reach USD 40.10 billion by 2024 from USD 16.55 billion in 2016, at a CAGR of 11.7% in the forecast period 2017 to 2024.

 

Based on geography, the Global Cancer Diagnostics Market is segmented into 5 geographical regions, such as,

 

North America,

South America,

Europe,

APAC,

MEA,

Rest of the World

 

Explore More Information about report @ https://www.researchcosmos.com/reports/cancer-diagnostics-market-analysis-global-industry-outlook-and-forecast-2017-to-2024/2106903149

 

Global cancer diagnostics market competition by top players including -

 

GE Healthcare is going to dominate the cancer diagnostics market, by imaging following with Siemens Healthcare GmbH along with others such as

Hologic, Inc,

Becton, Dickinson & Company.

 

Request free sample @ https://www.researchcosmos.com/request/2106903149

 

Thermo Fisher Scientific, Inc. is going to dominate the cancer diagnostics market, by platform based following with Illumina, Inc. along with others such as

 

Roche Diagnostics,

Abbott Laboratories, Inc.

Qiagen.

 

The global cancer diagnostics market is segmented on the basis of technology, application and geography.

 

Inquire before buying @ https://www.researchcosmos.com/inquire/2106903149

 

The global cancer diagnostics market is segmented into 2 types, namely platform based and instrument based.

 

Cancer diagnostics platform based market is segmented into Polymerase Chain Reaction (PCR), In Situ Hybridization (ISH), Immunohistochemistry (IHC), Next Generation Sequencing (NGS), DNA microarrays, flow cytometry and others.

 

Check for discount @ https://www.researchcosmos.com/discount/2106903149

 

Cancer Diagnostics instrument based market is segmented into imaging and biopsy. Imaging is further segmented into Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron Emission Tomography- Computed Tomography (PET-CT), mammography and ultrasound.

 

On the basis of application, the market is segmented into lung cancer, breast cancer, colorectal cancer, melanoma and others.

 

About Us:

Research Cosmos is an aggregator of syndicated and bespoke market research, business intelligence and consulting services on gamut of sectors across the globe. We’re associated with world renowned publishers who when combined, serve hundreds of fortune listed companies and publish wide range of insightful reports which cover nook and corner of every industry vertical.

 

Contact:

Dani Rodriguez

Partner Relation Executive

Research Cosmos

Direct Line: +1 888 709 8757

Mail: dani@researchcosmos.com

 

www.researchcosmos.com

blog comments powered by Disqus
Comunicati.net è un servizio offerto da Factotum Srl